FDA.reportPublic FDA data

Turalio 125 MG Oral Capsule

RxCUI
2626399
RxNorm name
Turalio 125 MG Oral Capsule
Display name
Turalio 125 MG Oral Capsule
Full name
Turalio 125 MG Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
7b0ec4bf-b2ac-49ee-96af-7740ad3f2e16Turalio 125 MG Oral CapsuleSY8These highlights do not include all the information needed to use TURALIO safely and effectively. See full prescribing information for TURALIO. TURALIO ® (pexidartinib) capsules, for oral use Initial U.S. Approval: 201920250116
7b0ec4bf-b2ac-49ee-96af-7740ad3f2e16pexidartinib 125 MG Oral Capsule [Turalio]SBD8These highlights do not include all the information needed to use TURALIO safely and effectively. See full prescribing information for TURALIO. TURALIO ® (pexidartinib) capsules, for oral use Initial U.S. Approval: 201920250116
7b0ec4bf-b2ac-49ee-96af-7740ad3f2e16Turalio 125 MG Oral CapsulePSN8These highlights do not include all the information needed to use TURALIO safely and effectively. See full prescribing information for TURALIO. TURALIO ® (pexidartinib) capsules, for oral use Initial U.S. Approval: 201920250116